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2532Background: We sought to evaluate the medium-term implications of fenestration status.
Methods: Between 1994 and 2012, 326 patients received an extracardiac Fontan (hospital mortality n ¼ 6,
1.8%). A fenestration was routinely created (n¼ 306, 94%) unless there was technical difficulty. Three hundred
patients discharged with an open fenestration were included. The primary end points were death and Fontan
failure. Secondary outcomes were Fontan complications such as venovenous collaterals, protein-losing
enteropathy, pacemaker requirement, and arrhythmias.
Results: The fenestration was closed in 260 patients: 185 as a catheter intervention (62%) and 75 (25%)
spontaneously. Forty patients (13%) had the fenestration open at a median follow-up period of 5.05 years.
Of these patients, catheter-based closure failed in 10 (3%). There was no statistically significant difference
in pre-Fontan hemodynamic parameters, such as pulmonary artery pressure and pulmonary vascular resistance
between the patients with open fenestration and the ones with closed fenestration. Patients with an open fenes-
tration had significantly more late deaths (P< .001), Fontan failure (P ¼ .021), and Fontan complications
(P ¼ .011) compared with those with a closed fenestration. Multivariable Cox regression revealed open fenes-
tration (P<.001) and indeterminate ventricular morphology (P ¼ .002) as risk factors for death/Fontan failure,
and ventricular dysfunction (P¼ .014) and open fenestration (P¼ .009) as risk factors for Fontan complications.
Conclusions: Persistent fenestration was a marker for physiologic intolerance as noted by increased rates of
mortality and a higher incidence of Fontan failure/complications. The specificity of pre-Fontan physiologic
data for fenestration status may not have the fidelity needed for long-term care and thus, the consequences of
decision making regarding fenestration status may not be determined until well after the operation. (J Thorac
Cardiovasc Surg 2014;148:2532-8)See related commentary on pages 2538-9.Surgical creation of a temporary communication between
the Fontan pathway and the common atrium, ie, fenestration,
was first introduced in the early 1990s as a strategy for high-
risk Fontan candidates who had an estimated hospital sur-
vival of less than 85%.1 The rationale for fenestration was
to lower the pressure in the Fontan circuit and increase car-
diac output, thereby decreasing operative mortality and
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Hospital survival for the Fontan operation in the current
era is excellent after refinements in surgical strategy
including fenestration and improvements in perioperative
management.
The impact of fenestration on early clinical outcomes in
standard-risk Fontan candidates has been studied in the
last 2 decades. There was no survival benefit of fenestration
reported and the survival of both fenestrated and
nonfenestrated patients with standard-risk profiles was
excellent. There were some positive effects of fenestration
on secondary outcomes, including chest tube drainage,
arrhythmias, and hospital stay,4-6 although some other
retrospective studies showed no clinical benefit of
fenestration.7,8 Much less evidence exists regarding the
medium- to long-term effects of persistent fenestration on
clinical outcomes. A retrospective study from the Pediatric
Heart Network showed no additional benefit of fenestration
on functional status and ventricular function at a mean
follow-up of 7 to 8 years.7 A recent cardiac magnetic
resonance study from our group showed that not only all
inferior vena cava flow but also part of the superior vena
cava flow is diverted through the fenestration in two thirds
of the study population at a mean follow-up of 12 months,gery c December 2014
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persistent fenestration in the medium-term.9
Like many North American institutes,10 Fontan
completion with an extracardiac tube graft with fenestration
of 3 to 4 mm has been our consistent approach over the past
2 decades. Our intention has been to close the fenestration
at 6 to 12 months after Fontan completion; nonetheless,
several patients did not tolerate fenestration closure. We
hypothesized that persistent fenestration does not have
medium-term hemodynamic benefit but failure to close the
fenestration may be an indicator of subsequent poor clinical
outcomes. Thus, we investigated the impact of persistent
fenestration on medium-term mortality and morbidity.METHODS
A total of 326 patients who underwent extracardiac total cavopulmo-
nary connection for single ventricle palliation at the Hospital for Sick
Children between July 1994 and April 2012 were reviewed. Research
Ethics Board approval was obtained. Patients who underwent a 1-stage
Fontan operation or aortopulmonary connection Fontan operation were
excluded. A fenestration was routinely created at our institution unless
there was technical difficulty. A total of 306 (94%) patients had a
fenestration. Three hundred patients who had an open fenestration at the
time of discharge were included in the study.
Operative Technique and Fenestration Closure
The surgical techniques for the Fontan operation have been
described elsewhere.11 Briefly, standard normothermic or mild hypothermic
cardiopulmonary bypass was used. Extracardiac total cavopulmonary
connection was typically performed in an on-pump beating state without car-
dioplegic cardiac arrest unless other intracardiac procedures were required. A
transverse incision was made on the inferior aspect of the central branch pul-
monary artery and a tube graft was anastomosed. The inferior end of the graft
was then anastomosed to the inferior vena cava. A fenestration incision was
made on the tube graft as well as on the right atrial lateral wall, and a fenes-
tration was created between the Fontan graft and the atrium by means of a
direct side-by-side anastomosis without a bridging graft. A polytetrafluoro-
ethylene tube (n¼ 254), aortic homograft (in the 1990s; n¼ 67), or another
conduit (n ¼ 5) was used as the external conduit. The average conduit size
was 20  1 mm (median, 21 mm; range, 20-22 mm). The median size of
the fenestration was 4 mm (range, 3.5-5 mm).
Catheter-based fenestration closure was performed electively at 6 to 12
months if physiologically tolerated. After initial assessment at the
outpatient clinic, patients were taken to the cardiac catheterization-
laboratory. Suitability for fenestration closure was decided based on
changes in the central venous pressure (Fontan pressure), systemic
blood pressure, and arterial oxygen saturation with test occlusion of the
fenestration. Fenestration closure was performed with an Amplatzer septal
occluder (AGA Medical, Golden Valley, Minn).
Outcome Assessment
All patient charts were independently reviewed by 3 investigators
(YK, AS, and JZ). Echocardiography was used to assess whether or notThe Journal of Thoracic and Carthe fenestration was open at latest follow-up and patients were divided
into 2 groups: closed fenestration and open fenestration. Outcomes were
compared between the 2 groups. Primary end points were death and Fontan
failure, defined as Fontan takedown/revision, need for mechanical
circulatory support, or transplantation.12-14 Secondary outcomes were
Fontan complications, including venovenous collaterals, protein-losing
enteropathy, pacemaker requirement, arteriovenous malformation, and
arrhythmias. Echocardiographic images were reviewed and qualitative
assessments of ventricular function and degree of arterioventricular
valve (AVV) regurgitation were performed using a method described
previously.15 Ventricular function was graded as normal, mildly reduced,
moderately reduced, or severely reduced. The degree of AVV regurgitation
was graded as none/trivial, mild, moderate, or severe.
Statistical Analysis
Continuous data are presented as median (interquartile range). Discrete
data are presented as frequency (percentage). Differences between the groups
were analyzed with the Mann-Whitney U test. Event frequencies were
compared with the c2 or Fisher test. Freedom from death/Fontan failure and
Fontan complications were analyzed by Kaplan-Meier analysis and the log-
rank test. Univariable predictors for death/Fontan failure and Fontan compli-
cations were analyzed with a Cox regression model. Variables that were sig-
nificant at the P  .05 level in univariable analysis were included in a
multivariable Cox regression model. Statistical analysis was performed using
SPSS version 17.0 statistical software (IBM Corporation, Armonk, NY).
RESULTS
Seventy-five (25%) patients were identified as having a
fenestration that closed spontaneously. A total of 195
(65%) patients were brought to the catheterization
laboratory for assessment of fenestration closure. Thirty
(10%) patients were considered too high risk for
fenestration closure and were not assessed by test occlusion.
Ten (3%) of 195 patients failed balloon test occlusion
because of high pulmonary artery pressure (n ¼ 7) or
hemodynamic instability (n ¼ 3). As a result, at a follow-
up period of 5.05 (2.37-10.26) years, the fenestration was
closed in 260 patients: 75 (25%) by spontaneous closure
and 185 (62%) by catheter-based closure. Forty patients
(13%) had an open fenestration. Therewas no statistical dif-
ference between those with open and closed fenestration
with respect to pre-Fontan status, including diagnosis, domi-
nant ventricle, ventricular and AVV function, pulmonary ar-
tery pressure, and pulmonary vascular resistance (Table 1).
Death and Fontan Failure
Nine (3%) patients died after discharge. Cause of death
included circulatory failure in 2 patients, respiratory failure
in 1 patient, multiorgan failure in 1 patient, thromboembo-
lism in 1 patient, and unknown in 4 patients. Freedom
from death in patients with a closed fenestration was signif-
icantly higher than that in patients with an open fenestration
(99.2% vs 74.5% at 5 years, P < .001; Figure 1, A).
A comparison of 3 groups (catheter-based closure,
n ¼ 185; spontaneous closure, n ¼ 75; and open, n ¼ 40)
showed that the mechanism of fenestration closure was not
important but the presence of an open fenestration was
associated with the lowest survival (spontaneous closure,diovascular Surgery c Volume 148, Number 6 2533
TABLE 1. Preoperative profile
Closed fenestration (n ¼ 260) Open fenestration (n ¼ 40) P
Patient demographics
Age, mo (range) 37.7 (31.2-45.5) 40.8 (33.8-54.5) .071
Body weight, kg (range) 13.7 (12.4-15.3) 14.2 (12.8-16.2) .191
Body surface area, m2 (range) 0.55 (0.51-0.59) 0.56 (0.52-0.61) .326
Male/female gender, n (%) 166 (64)/94 (36) 25 (63)/15 (37) .869
Diagnosis, n (%)
Hypoplastic left heart syndrome 60 (23) 8 (20) .665
Double inlet left ventricle 42 (16) 6 (15) .853
Tricuspid atresia 42 (16) 6 (15) .853
Unbalanced atrioventricular septal defect 6 (2) 3 (8) .104
Double outlet right ventricle 15 (6) 5 (13) .162
Univentricular heart 54 (21) 3 (8) .051
Isomerism 23 (9) 6 (15) .220
Pulmonary artesia/intact ventricular septum 18 (7) 3 (8) .749
Dominant ventricle, n (%)
Left 154 (59) 19 (48) .162
Right 91 (35) 19 (48) .127
Indeterminate 15 (6) 2 (5) 1.000
Echocardiography
Atrioventricular valve regurgitation, n (%)
None/mild 73 (28)/156 (60) 8 (20)/28 (70) .278/.237
Moderate/severe 30 (12)/0 (0) 3 (8)/0 (0) .592/–
Ventricular function, n (%)
Normal/mildly decreased 247 (95)/12 (5) 37 (93)/3 (8) .433/.433
Moderately decreased/severely decreased 0 (0)/0 (0) 0 (0)/0 (0) –/–
Catheterization
Mean pulmonary artery pressure, mm Hg (range) 10 (9-12) 11 (9-12) .489
Pulmonary vascular resistance, Wood units (range) 1.8 (1.0-2.5) 1.9 (1.6-2.4) .491
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tion; 74.5% at 5 years, P<.001; Figure 1, B). Three (1%)
patients had Fontan failure (1 patient with open fenestration
and 2 patients with closed fenestration). Freedom from
death/Fontan failure in patients with closed fenestrationFIGURE 1. Freedom from death between open and closed fenestration (A) a
curve showed that the mechanism of fenestration closure was not important but t
2534 The Journal of Thoracic and Cardiovascular Surwas significantly higher compared with patients with open
fenestration (99.2% vs 68.6% at 5 years, P<.001).
Multivariable Cox regression revealed open fenestration
(P < .001) and indeterminate ventricular morphology
(P ¼ .002) as risk factors for death/Fontan failure.nd stratified by mechanism of fenestration closure (B). The Kaplan-Meier
he presence of an open fenestration was associated with the lowest survival.
gery c December 2014









Ventricular dysfunction 9 (3) 2 (5) .646
Pulmonary vascular dysfunction 2 (1) 4 (10) .003
Mechanical problem 21 (8) 1 (3) .330
Thromboembolism 8 (3) 2 (5) .628
Arrhythmia 6 (2) 1 (3) 1.000
Others
Protein-losing enteropathy 4 (2) 1 (3) .514
Plastic bronchitis 0 (0) 1 (3) .133
Arteriovenous malformation 4 (2) 0 (0) 1.000
Venovenous collaterals 38 (15) 2 (5) .132
Aortopulmonary collaterals 13 (5) 1 (2) .702
Arteriovenous fistula 2 (1) 0 (0) 1.000
Unknown 3 (1) 0 (0) 1.000
Pulmonary vascular dysfunction was defined as pulmonary artery pressure>15mmHg
or pulmonary vascular resistance>4 Wood units.




One hundred twenty (40%) patients developed Fontan
complications. The occurrence of ventricular dysfunction,
arrhythmias, and protein-losing enteropathy was compara-
ble between patients with open and closed fenestration;
however, pulmonary vascular dysfunction was more
frequently seen in the open fenestration group (10% vs
1%, P ¼ .003; Table 2). Freedom from Fontan complica-
tions in patients with a closed fenestration was significantly
higher than that in patients with an open fenestration
(57.7% vs 13.9% at 5 years, P ¼ .011; Figure 2, A). A
comparison of 3 groups (catheter-based closure,
spontaneous closure, and open fenestration) showed that
the mechanism of fenestration closure was not importantFIGURE 2. Freedom from Fontan complications between open and closed
The Kaplan-Meier curve showed that the mechanism of fenestration closure w
with the most complications.
The Journal of Thoracic and Carbut the presence of an open fenestration was associated
with the occurrence of Fontan complications (P ¼ .008;
Figure 2, B). Multivariable Cox regression showed
ventricular dysfunction (P ¼ .014) and open fenestration
(P ¼ .009) as risk factors for Fontan complications.Clinical Status
A summary of the latest clinical status is shown in
Table 3. The need for surgical or catheter reintervention
was comparable between the groups (surgery, closed 7%
vs open 11%, P ¼ .498; catheter, closed 36% vs open
24%, P ¼ .175). Most (84%) of the patients with a closed
fenestration were New York Heart Association (NYHA)
class I, whereas approximately half of the patients with an
open fenestration were NYHA class I. Three (8%) patients
with an open fenestration were NYHA class IV. There was
no difference in the rate of significant (moderate or more)
AVV regurgitation and ventricular dysfunction between
the groups. Patients with an open fenestration had higher
pulmonary artery pressure and pulmonary vascular
resistance (mean pulmonary artery pressure, 13.5 vs
12.0 mm Hg, P ¼ .004; pulmonary vascular resistance,
4.5 vs 1.6 Wood units) at follow-up cardiac catheterization.
Patients with open fenestration required more medication,
especially anticoagulation.DISCUSSION
The fenestrated Fontan strategy was introduced for
high-risk patients with high pulmonary artery pressure
and ventricular dysfunction.1,16 The advantages of
fenestration include reduction of early Fontan failure and
chest tube drainage and improvement in postoperative
recovery.1,15,16 Recent refinements in patient selection,fenestration (A) and stratified by mechanism of fenestration closure (B).
as not important but the presence of an open fenestration was associated
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TABLE 3. Follow-up status
Closed fenestration (n ¼ 260) Open fenestration (n ¼ 40) P
Reintervention, n (%)
Surgery 19 (7) 4 (11) .498
Catheter 93 (36) 8 (24) .175
Follow-up data, n (%)
NYHA class
I/II 218 (84)/18 (7) 22 (55)/6 (15) <.001/.043
III/IV 10 (4)/1 (0) 3 (8)/3 (8) .198/.006
Echocardiography
Atrioventricular valve regurgitation, n (%)
None/mild 53 (20)/168 (65) 8 (20)/27 (68) .955/.859
Moderate/severe 38 (15)/1 (0) 4 (10)/1 (3) .624/.249
Ventricular function, n (%)
Normal/mildly reduced 248 (95)/8 (3) 36 (90)/2 (5) .245/.628
Moderately reduced/severely reduced 3 (1)/1 (0) 0 (0)/2 (5) 1.000/.048
Catheterization at follow-up (n ¼ 231)
Time from Fontan, y (range) 1.11 (0.72-1.77) 1.09 (0.86-2.21) .914
Pulmonary vascular resistance, Wood units (range) 1.6 (1.1-2.5) 4.5 (3.8-4.6) .001
Mean pulmonary artery pressure, mm Hg (range) 12.0 (11.0-13.0) 13.5 (12.5-16.5) .004
Heart transplantation, n (%)
Listed/transplanted 16 (6)/3 (1) 4 (10)/2 (5) .320/.134
Medication (n ¼ 248) (n ¼ 20)
Anticoagulation, n (%)
None 94 (38) 0 (0) <.001
Acetylsalicylic acid 132 (53) 8 (40) .183
Warfarin 19 (8) 11 (55) <.001
Low-molecular-weight heparin 0 (0) 1 (5) .078
Clopidogrel 3 (1) 0 (0) 1.000
Related to heart medication/none, n (%) 84 (34)/142 (57) 14 (70)/4 (20) .001/.002
b-Blocker 17 (7) 3 (15) .178
Digoxin 14 (6) 1 (5) 1.000
Sildenafil 2 (1) 5 (25) <.001
Acetylcholinesterase inhibitor 69 (28) 9 (45) .104
Diuretics 12 (5) 7 (35) <.001
Antiarrhythmics other than b-blocker 0 (0) 1 (5) .075
Corticosteroids/nonrelated drugs 6 (2)/52 (21) 2 (10)/8 (40) .113/.050
NYHA, New York Heart Association.
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brought a significant improvement in early outcome for
even high-risk patients, raising the question whether
fenestration is necessary for all patients including
standard-risk patients.7,8 Because the medium- to
long-term effects of fenestration are not well known, there
is no universal agreement on whether routine surgical
creation of fenestration is warranted.
We specifically examined the association between
fenestration status and medium-term clinical outcomes,
including death, Fontan failure, and Fontan complications.
With our current strategy to routinely create and close the
fenestration for all patients, 25% of patients were identified
as having a spontaneously closed fenestration. Approxi-
mately two thirds of patients had a successful catheter-
based fenestration closure. Thirty (10%) patients still had a
physiologic need for fenestration, including 3% of patients2536 The Journal of Thoracic and Cardiovascular Surin whom attempts to close the fenestration failed. Another
key finding from this study is that open fenestrations were
associated with more death, Fontan failure, and Fontan com-
plications. Therewere no predictors for death, Fontan failure,
and Fontan complications identified from the preoperative
variables, such as ventricular function or pulmonary artery
pressure, suggesting difficulty in determining whether or
not fenestration is needed before Fontan completion. This,
combined with the fact that late poor outcomes are mainly
associated with ventricular dysfunction and pulmonary
vascular problems, suggests that fenestration is important
for maintaining the Fontan circulation for a small proportion
of patients with unfavorable Fontan physiology.
Spontaneous Fenestration Closure
This study revealed that approximately one quarter of
patients had spontaneous fenestration closure. This subgroupgery c December 2014
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any Fontan complications. Based on the clinical data, this
subgroup has the most efficient Fontan physiology so they
do not need to use the fenestration. The lack of effective
flow through the fenestration is likely the main mechanism
of spontaneous closure. The recent Pediatric Heart Network
study showed that 19% of patients had spontaneous closure
at 8 years after a Fontan operation.7 Other studies showed
spontaneous closure rates of 8% at 2.4 years after surgery17
and 29% within 3 months after surgery.18 The difference in
frequency of spontaneous closure may be associated with
the institutional strategy for fenestration closure and
surgical technique. Some centers routinely bring patients to
the catheterization laboratory for fenestration closure at
various time points after surgery and others do not. Our
surgical technique to create the fenestration is direct
side-by-side anastomosis between the Fontan graft and the
common atrial wall. This technique may have a slightly
higher spontaneous closure rate compared with fenestration
with a bridging graft because of the right atrial trabeculation.
Our data indicate that spontaneous closure of fenestration is
generally associatedwith a favorablemedium-term outcome.
The rationale for considering fenestration closure is that
the positive effects of fenestration in Fontan physiology are
limited to the early recovery period. Also there are some
potential disadvantages of a long-term open fenestration,
including persistent low arterial oxygenation, paradoxic
embolization, and deleterious effects on neurologic and
ventricular function.7,19 However, certain studies have
shown no difference in functional status, ventricular
function, and occurrence of stroke and thrombosis.10,20,21
Fenestration and Late Clinical Outcomes
This study shows that patients with an open fenestration
had an increased risk of death, Fontan failure, and Fontan
complications. Imielski and colleagues17 reported that there
was no difference in event-free survival including heart
transplantation, arrhythmia, and protein-losing enteropathy
between the open and closed fenestration groups. These
investigators suggested early fenestration closure before
Fontan complications occur.17 They showed a significant
number (76% of the entire cohort) of patients had an
open fenestration at a follow-up period of 2.4 years even
though they routinely assessed suitability for catheter-
based fenestration closure at 1 to 3 years after surgery.
One possible reason is that an adverse event occurred before
fenestration closure and such patients might be considered
too high-risk to close the fenestration. Our strategy has
been the routine creation of a fenestration followed by
routine assessment for fenestration closure within 1 year.
Although the optimal timing of fenestration closure has
not been well elucidated, we believe that patients without
any evidence of ventricular dysfunction and pulmonary
vascular problems should be able to have fenestrationThe Journal of Thoracic and Carclosure once they recover from surgery. Patients, who are
not candidates for fenestration closure or had a failed
fenestration closure at 6 to 12 months need the fenestration
to maintain Fontan circulation. Therefore, it is not
surprising that patients with open fenestration have an
increased risk for late adverse events.
Our data clearly indicate that failure to close the
fenestration at 6 to 12 months is an indicator of subsequent
Fontan complications, Fontan failure, and death. Those
patients should be carefully monitored and proactively
treated for their complications. Early induction of
pulmonary vasodilator therapy and early consideration of
Fontan takedown or heart transplantation may bewarranted.Is Fenestration Necessary in All Patients?
Surgical creation of fenestration in standard-risk patients
has been controversial and remains controversial after
conducting this study. There is a reasonable body of
evidence that fenestration expedites postoperative recovery
by lowering Fontan pressure and increasing cardiac output
in high-risk patients.1,4,20 The only prospective
randomized study to assess the need for fenestration in
standard-risk patients showed decreased chest tube
drainage, less requirements for additional procedures,
and subsequent shorter hospitalization.4 Some studies,
however, showed no difference in these postoperative
clinical outcomes in standard-risk patients, suggesting
fenestration is not required in most patients.7,8 Thompson
and colleagues7 create a fenestration based on a postbypass
Fontan pressure guideline.
One important result from our study is that all pre-Fontan
factors including diagnosis, ventricular function, pulmo-
nary artery pressure, and pulmonary vascular resistance
did not predict failure to close the fenestration. This result
highlights the difficulty with predicting who is going to
need a fenestration in the long-term and who is going to
have subsequent Fontan failure. Our previous study also
showed that pulmonary vascular resistance is not always a
discriminator of subsequent successful fenestration
closure.9 A significant contribution to cardiac output with
fenestration flow is important to distinguish patients who
are eligible for fenestration closure. This is also difficult
to know before Fontan completion. Given the unpredictable
nature of fenestration requirements, routine creation of a
fenestration in the standard-risk patient still seems to be a
reasonable strategy, recognizing that many patients do not
need fenestration at any point after Fontan completion
and complications associated with fenestration closure are
not negligible.Study Limitations
The main limitation of this study is its retrospective
nature.diovascular Surgery c Volume 148, Number 6 2537




Spontaneous fenestration closure is likely an indicator of
good Fontan physiology and a favorable clinical outcome.
Persistent fenestration at 6 to 12 months was a marker for
physiologic intolerance as noted by higher mortality and a
higher incidence of Fontan failure/complications. Late
fenestration patency was clearly important in 3% of the
total population. The specificity of pre-Fontan physiologic
data for fenestration status may not have the fidelity needed
for long-term care and thus, the consequences of decision
making regarding fenestration status may not be determined
until well after the operation.References
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